CompletedNCT00259272

Testing a mood assessment scale in adults with bipolarity taking olanzapine

About this title

Medication studyAges 18+France

The study in practice

Understand this study

Listed age limits: from 18 years.

The study group receives olanzapine as a study medication.

Listed locations: Andilly and 15 more locationsSee all locations and recruitment
Study phase: Phase 3

Study clarity

Study start dateNovember 2005

Recruitment status: Completed
Enrollment listed in the registry: 141
Sponsor: Eli Lilly and Company
Sponsor type: Other organization
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: France
Age range: Over 18 Years
Official registry ID: NCT00259272
Official title: Show the full official title
Phase IIIb, Multicenter, Single-Arm Open-Label Study, Supporting the Development and the Validation of the MATHYS Scale (Multidimensional Assessment of THYmic States) in a Population of Bipolar Patients Treated With Olanzapine, Either in-Label (Manic and Mixed Patients) and Off-Label (Hypomanic and Bipolar Depression)

Completed

Andilly · Bordeaux · Cornebarrieu

13 more locations

FAQ

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including olanzapine.

Who was this study for?

Listed age limits: from 18 years.